An Immediate Instillation after Transurethral Resection of Bladder Tumor in Non-Muscle-Invasive Bladder Cancer: Has the Evidence Changed?

European Urology

Volumn 56, Issue 1, 2009, Pages 43-45

  Sylvester, Richard J ^a   Oosterlinck, Willem ^b  

^a EORTC DATA CENTER   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; EPIRUBICIN;

BLADDER CANCER; BLADDER PERFORATION; BLADDER TUMOR; CANCER CHEMOTHERAPY; CANCER INVASION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; EDITORIAL; EXTRAVASATION; HEALTH CARE COST; HEALTH CARE SYSTEM; HIGH RISK PATIENT; HUMAN; MEDICAL SOCIETY; MULTIPLE CANCER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; TRANSURETHRAL RESECTION; TUMOR RECURRENCE;

ADMINISTRATION, INTRAVESICAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COST-BENEFIT ANALYSIS; DRUG ADMINISTRATION SCHEDULE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE PERIOD; TRANSURETHRAL RESECTION OF PROSTATE; URINARY BLADDER NEOPLASMS;

EID: 67349127589     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.03.074     Document Type: Editorial

References (10)

1. Berrum-Svennung I., Gransfors T., Jahnson S., Boman H., and Holmang S. A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences. J Urol 179 (2008) 101-106
2. Gudjónsson S., Adell L., Merdasa F., et al. Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study. Eur Urol 55 (2009) 773-780
3. Cai T., Nesi G., Tinacci G., et al. Can early single dose instillation of epirubicin improve bacillus Calmette-Guérin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study. J Urol 180 (2008) 110-115
4. Babjuk M., Oosterlinck W., Sylvester R., Kaasinen E., Böhle A., and Palou-Redorta J. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 54 (2008) 303-314
5. Hall M.C., Chang S.S., Dalbagni G., et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178 (2007) 2314-2330
6. Sylvester R.J., Oosterlinck W., and van der Meijden A.P.M. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 171 (2004) 2186-2190
7. Sylvester R.J., Oosterlinck W., and O'Donnell M. Letter to the editor. Re: Cai, T, Nesi G, Tinacci G et al. Can early single dose instillation of epirubicin improve bacillus Calmette-Guérin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study. J Urol 181 (2009) 410
8. In: Oosterlinck W., and Sylvester R. (Eds). Letter to the editor. Re: Berrum-Svennung I, Gransfors T, Jahnson S, Boman H and Holmang S. A single instillation of epirubicin after transurethral resection of bladder tumors prevents only small recurrences. J Urol 180 (2008) 2255-2256
9. Solsona E., Iborra I., Ricos J.V., Monros J.L., Casanova J., and Dumont R. Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow up. J Urol 161 (1999) 1120-1123
10. Sylvester R.J., Oosterlinck W., and Witjes J.A. The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials. Eur Urol 53 (2008) 709-719